We support startup business growth by utilizing our pharmaceutical drug discovery research and business development experience at pharmaceutical companies, and our experience in introducing and deriving and evaluating research assets in Japan and Boston, USA. We will contribute to revitalizing the Japanese venture ecosystem based on recognition of issues such as differences in the environment surrounding startups in Japan and the US.
Yoshiharu joined VGI in 2022. Prior to joining VGI, he worked for Sumitomo Pharma as a medicinal chemist for 10 years. His main research areas are central nervous system and oncology. From 2019 to 2021, he worked at External Innovation Department in the US subsidiary of Sumitomo Pharma as associate director, and managed collaborative research projects with Harvard University etc. and evaluated research assets of startup companies. He was also in charge of search & evaluation, innovative technology development and business development for healthcare areas.
Ph.D in pharmaceutical science from Kyoto University
Pharmacist
Venture Capitalist / Life Science Professional
